Regeneron Pharmaceuticals
REGN
#290
Rank
A$116.32 B
Marketcap
A$1,100
Share price
-0.23%
Change (1 day)
0.38%
Change (1 year)

Regeneron Pharmaceuticals (REGN) - Total liabilities

Total liabilities on the balance sheet as of December 2025 : A$13.12 Billion

According to Regeneron Pharmaceuticals's latest financial reports the company's total liabilities are A$13.12 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Regeneron Pharmaceuticals - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2025-12-31A$13.88 B2.76%
2024-12-31A$13.51 B29.55%
2023-12-31A$10.43 B8.37%
2022-12-31A$9.62 B4.69%
2021-12-31A$9.19 B15.19%
2020-12-31A$7.98 B50.42%
2019-12-31A$5.30 B25.57%
2018-12-31A$4.22 B25.92%
2017-12-31A$3.35 B-4.16%
2016-12-31A$3.50 B30.54%
2015-12-31A$2.68 B70.53%
2014-12-31A$1.57 B40.47%
2013-12-31A$1.11 B39.36%
2012-12-31A$0.80 B-1.66%
2011-12-31A$0.81 B47.79%
2010-12-31A$0.55 B44.2%
2009-12-31A$0.38 B-10.63%
2008-12-31A$0.42 B-21.19%
2007-12-31A$0.54 B16.48%
2006-12-31A$0.46 B10.5%
2005-12-31A$0.42 B12.65%
2004-12-31A$0.37 B-18.37%
2003-12-31A$0.45 B5.52%
2002-12-31A$0.43 B-2.87%
2001-12-31A$0.44 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Johnson & Johnson
JNJ
A$166.05 B 1,164.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$90.88 B 592.34%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Amgen
AMGN
A$113.63 B 765.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$93.17 B 609.83%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
A$15.78 B 20.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
A$5.89 B-55.09%๐Ÿ‡บ๐Ÿ‡ธ USA